Centerline Biomedical news

Thank you to Dr. Gustavo Oderich, Dr Satish Muluk, and Dr. Dan Clair for moderating The IOPS Symposium session at #VAM21, “Navigating the New Vision of Endovascular Medicine”.

Several challenging IOPS cases were presented as well as dialogue with an audience of distinguished vascular surgeons treating complex aortic disease.

We are excited to share another successful case with IOPS at Allegheny General Hospital. Dr. Carlos Rosales and his vascular team successfully used IOPS to cannulate both renal arteries without fluoro or contrast during an extremely complex Aortic repair. Once he cannulated the arteries with IOPS, he confirmed his position with traditional 2D fluoro and successfully completed the AAA renal chimney procedure.

We are excited to share our full presentation from LSI 2021! We are incredibly proud of our IOPS technology and the impact it is having on procedural quality, safety, and efficiency for patients, caregivers, and staff.

Centerline Biomedical presenting at LSI 2021: Emerging MedTech Summit

LSI 2021 – Emerging MedTech Summit

We are honored to be selected as a presenter at the upcoming #LSI2021 Emerging Medtech Summit! Our CEO Philip Rackliffe looks forward to sharing more about the IOPS™ Technology.

To learn more, visit the LSI 2021 website: https://www.lifesciencemarketresearch.com/medtech-summit

Centerline Biomedical, Inc. (Centerline) announced Tuesday the completion of the first surgical case in its MOTION clinical study of its innovative Intra-Operative Positioning System (IOPS™) surgical navigation platform. The FDA-cleared technology is already being deployed in a controlled launch at Cleveland Clinic and other leading institutions in the United States. The MOTION study will be used to support the company’s submission for market clearance in 

The annual TechConnect Defense Innovation Awards recognizes the top 15% of submitted Challenge technologies as ranked by the Selection Committee. To see the full list of awardees, visit https://events.techconnect.org/DTCFall/awards.html

Centerline Biomedical will be featured during the “Biotech/Medical II: Innovation Spotlights” session in the upcoming Virtual Defense TechConnect Summit and Expo. To lear

Surgical navigation startup Centerline Biomedical, Inc. (Centerline), a Cleveland Clinic spin-off company, has announced the successful completion of the first in a series clinical cases in the United States as it begins limited launch of its innovative IOPS™ technology platform. The FDA-cleared technology is being deployed at Cleveland Clinic to begin, with other leading institutions to follow, in preparation for larger-scale multi-center clinical studies.

Centerline Biomedical, Inc. (Centerline) announced on April 21, 2020 the receipt of a Direct to Phase II Small Business Innovation Research (SBIR) grant award from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH). This represents the fourth small business grant awarded to the startup founded to commercialize and innovate IOPS™, a novel image guidance technology platform originally developed at Cleveland Clinic.

The IOPS™ pl